
    
      This prospective, non-randomized, multi-center study includes subjects who meet all of the
      inclusion and none of the exclusion criteria and sign the ICF. This study may treat up to
      approximately 500 subjects at up to 50 active sites in the U.S. Subjects may be followed up
      to three (3) years. Subjects will be stratified into one (1) of three (3) arms based on the
      degree of calcification in the coronary lesion as defined by this protocol. The duration of
      the study is expected to be approximately four (4) years.
    
  